HopeStage
Back to all studies
CompletedNCT02341131

Cognitive Remediation Therapy and Brain-Derived Neurotrophic Factor in Schizophrenia

About this titleRead the official source — NCT02341131
Behavioural studyAges 18–65Spain
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
BarcelonaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2012
Recruitment status
Completed
Enrollment listed in the registry
70
Sponsor
Hospital Clinic of Barcelona
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural
Locations
Spain
Age range
From 18 Years to 65 Years
Official registry ID
NCT02341131
Official title
Show the full official title

BDNF as a Potential Biomarker for Cognitive Remediation Therapy in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Barcelona

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Hospital Clinic of Barcelona, a hospital or academic medical center.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies